Jackson Hole Capital Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Jackson Hole Capital Partners's XBI Position: Q1 2026 in Review
Jackson Hole Capital Partners held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 940 shares worth $120K. The position accounts for 0.02% of the portfolio, ranked #234.
Jackson Hole Capital Partners first reported a position in XBI in Q4 2018 and has held it in 30 quarters since. The position peaked at $203K in Q4 2020. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Jackson Hole Capital Partners held 940 shares of State Street SPDR S&P Biotech ETF worth $120K as of Q1 2026.
- Jackson Hole Capital Partners left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
- State Street SPDR S&P Biotech ETF made up 0.02% of Jackson Hole Capital Partners's portfolio in Q1 2026, its #234 holding.
- Jackson Hole Capital Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 30 quarters since.
- Jackson Hole Capital Partners's State Street SPDR S&P Biotech ETF position peaked at $203K in Q4 2020.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Jackson Hole Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.